Buys
Open market- Shares
- +365,853
- Avg price
- $41.00
- Total value
- +$14,999,936
Nimish P. Shah - Director at Apogee Therapeutics, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- APGE on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Nimish P. Shah in Apogee Therapeutics, Inc.
Sells
Open market- Shares
- Avg price
- Total value
Net
Past year- Shares
- +365,853
- Share %
- 100%
- Total value
- +$14,999,936
Reported holdings for Nimish P. Shah in Apogee Therapeutics, Inc.
Form 4 holding
Director
Apogee Therapeutics, Inc.
- Security class
- Pre-Funded Warrants (Right to Buy)
- Shares / value
- 365,853
- Estimated value
- $14,999,936
- Report date
- 10 Oct 2025
- Price
- $41.00
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
Apogee Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 7,657
- Estimated value
- Report date
- 09 Jun 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Nimish P. Shah in Apogee Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.